Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ted Bader

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
The American Journal of Gastroenterology|May 7, 2010
The myth of statin-induced hepatotoxicityTed Bader
Lancet (London, England)|November 27, 2010
Liver tests are irrelevant when prescribing statinsTed Bader
Journal of Hepatology|October 4, 2011
Yes! Statins can be given to liver patientsTed Bader
Antiviral Research|March 10, 2010
Simvastatin potentiates the anti-hepatitis B virus activity of FDA-approved nucleoside analogue inhibitors in vitroTed Bader, Brent Korba
Digestive Diseases and Sciences|January 29, 2010
Statins improve ALT values in chronic hepatitis C patients with abnormal valuesMohammad F Madhoun, Ted Bader
Nature Clinical Practice. Gastroenterology & Hepatology|November 26, 2008
A case of hearing loss associated with pegylated interferon and ribavirin treatment ameliorated by prednisoneVu Le, Ted Bader, Javid Fazili
The American Journal of the Medical Sciences|January 21, 2010
Hepatitis C prevalence in patients with hepatocellular carcinoma without cirrhosisMohammad F Madhoun, Javid Fazili, Brianna C Bright, et al.
The American Journal of Gastroenterology|April 16, 2008
Fluvastatin inhibits hepatitis C replication in humansTed Bader, Javid Fazili, Mohammed Madhoun, et al.
Journal of Virology|September 23, 2011
Hepatitis C virus-induced cancer stem cell-like signatures in cell culture and murine tumor xenograftsNaushad Ali, Heba Allam, Randal May, et al.
Plos One|November 22, 2013
Fluvastatin interferes with hepatitis C virus replication via microtubule bundling and a doublecortin-like kinase-mediated mechanismNaushad Ali, Heba Allam, Ted Bader, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
The American Journal of Gastroenterology|May 7, 2010
The myth of statin-induced hepatotoxicityTed Bader
Lancet (London, England)|November 27, 2010
Liver tests are irrelevant when prescribing statinsTed Bader
Journal of Hepatology|October 4, 2011
Yes! Statins can be given to liver patientsTed Bader
Antiviral Research|March 10, 2010
Simvastatin potentiates the anti-hepatitis B virus activity of FDA-approved nucleoside analogue inhibitors in vitroTed Bader, Brent Korba
Digestive Diseases and Sciences|January 29, 2010
Statins improve ALT values in chronic hepatitis C patients with abnormal valuesMohammad F Madhoun, Ted Bader
Nature Clinical Practice. Gastroenterology & Hepatology|November 26, 2008
A case of hearing loss associated with pegylated interferon and ribavirin treatment ameliorated by prednisoneVu Le, Ted Bader, Javid Fazili
The American Journal of the Medical Sciences|January 21, 2010
Hepatitis C prevalence in patients with hepatocellular carcinoma without cirrhosisMohammad F Madhoun, Javid Fazili, Brianna C Bright, et al.
The American Journal of Gastroenterology|April 16, 2008
Fluvastatin inhibits hepatitis C replication in humansTed Bader, Javid Fazili, Mohammed Madhoun, et al.
Journal of Virology|September 23, 2011
Hepatitis C virus-induced cancer stem cell-like signatures in cell culture and murine tumor xenograftsNaushad Ali, Heba Allam, Randal May, et al.
Plos One|November 22, 2013
Fluvastatin interferes with hepatitis C virus replication via microtubule bundling and a doublecortin-like kinase-mediated mechanismNaushad Ali, Heba Allam, Ted Bader, et al.
Pageof 1